EML

The Eastern Company

53
Fundamentals57/ 100
Valuation34/ 100
Upside potential59/ 100
Risk potential22/ 100

EML has lower modeled downside risk, despite its lower overall score.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB has the edge over EML overall, supported by stronger valuation and stronger fundamentals.

EML Fundamentals

MetricStatus
Healthy
Healthy
Under pressure
Stable

EML's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is under pressure.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

EML PE Valuation

CHEAPFAIREXPENSIVE8.3x17x25x33x
CHEAPFAIREXPENSIVE8.3x17x25x33x
LevelPEPriceVs current
Cheap9.4x$16.97-45%
Fair14x$25.80-16%
Current17x$30.81—
Expensive21x$37.74+23%

Historical ranges are pointers, not guarantees.

EML's PE is in its expensive range at 17x.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

EML Forward outlook

There aren't enough analyst estimates for EML to show an outlook.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

EML Risk to reward

ScenarioChangePrice
Upside+32%$40.56
Downside-22%$24.05

Calculated from the latest close: $30.81 on Nov 12.

EML trails RKLB on modeled risk to reward, with less potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB has a better modeled risk to reward balance than EML, with more potential upside relative to its potential downside.

EML Earnings Per Share

Q4 2023: $1.37Q1 2024: $1.58Q2 2024: $1.92Q3 2024: $-1.03Q4 2024: $-1.37Q1 2025: $-1.36Q2 2025: $-1.36Q3 2025: $1.20Q1 2026: $1.17Q2 2026: $0.96Q3 2026: $1.34Q4 2026: $1.81
Q4 2023: $1.37Q1 2024: $1.58Q2 2024: $1.92Q3 2024: $-1.03Q4 2024: $-1.37Q1 2025: $-1.36Q2 2025: $-1.36Q3 2025: $1.20Q1 2026: $1.17Q2 2026: $0.96Q3 2026: $1.34Q4 2026: $1.81
QuarterTTM EPSYoY
Q3 2026$1.81+51%
Q2 2026$1.34+$2.70
Q1 2026$0.96+$2.32
Q4 2025$1.17+$2.54
Q3 2025$1.20+$2.23
Q2 2025-$1.36-171%
Q1 2025-$1.36-186%
Q4 2024-$1.37-200%

EML has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

EML Quarterly Revenue

Q4 2023: $67MQ1 2024: $68MQ2 2024: $73MQ3 2024: $71MQ4 2024: $67MQ1 2025: $63MQ2 2025: $70MQ3 2025: $55MQ1 2026: $58MQ2 2026: $60MQ3 2026: $62MQ4 2026: $75M
Q4 2023: $67MQ1 2024: $68MQ2 2024: $73MQ3 2024: $71MQ4 2024: $67MQ1 2025: $63MQ2 2025: $70MQ3 2025: $55MQ1 2026: $58MQ2 2026: $60MQ3 2026: $62MQ4 2026: $75M
QuarterRevenueYoY
Q3 2026$75M+35%
Q2 2026$61.8M-12%
Q1 2026$59.7M-5.7%
Q4 2025$57.5M-14%
Q3 2025$55.3M-22%
Q2 2025$70.2M-4.1%
Q1 2025$63.3M-6.8%
Q4 2024$66.7M-0.5%

EML's revenue has held roughly level: $75M last quarter, up 35% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over EML on sales, with more consistent year-over-year improvement.

EML Free Cash Flow

Q4 2023: $6MQ1 2024: $2MQ2 2024: $6MQ3 2024: −$7MQ4 2024: $9MQ1 2025: −$3MQ2 2025: $3MQ3 2025: $3MQ1 2026: $2MQ2 2026: $3MQ3 2026: $8MQ4 2026: −$4M
Q4 2023: $6MQ1 2024: $2MQ2 2024: $6MQ3 2024: −$7MQ4 2024: $9MQ1 2025: −$3MQ2 2025: $3MQ3 2025: $3MQ1 2026: $2MQ2 2026: $3MQ3 2026: $8MQ4 2026: −$4M
QuarterFree cash flowYoY
Q3 2026-$4M-232%
Q2 2026$7.9M+164%
Q1 2026$2.6M+$5.3M
Q4 2025$1.5M-83%
Q3 2025$3.1M+$9.8M
Q2 2025$3M-47%
Q1 2025-$2.7M-250%
Q4 2024$9M+62%

EML has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

EML Total Shares

Q4 2023: 6MQ1 2024: 6MQ2 2024: 6MQ3 2024: 6MQ4 2024: 6MQ1 2025: 6MQ2 2025: 6MQ3 2025: 6MQ1 2026: 6MQ2 2026: 6MQ3 2026: 6MQ4 2026: 6M
Q4 2023: 6MQ1 2024: 6MQ2 2024: 6MQ3 2024: 6MQ4 2024: 6MQ1 2025: 6MQ2 2025: 6MQ3 2025: 6MQ1 2026: 6MQ2 2026: 6MQ3 2026: 6MQ4 2026: 6M
PeriodChange %Net change
Quarterly0%-1.4K shares
1 year-0.9%-54.2K shares
3 years-3.9%-245K shares
5 years-3.9%-243K shares
Available history-3.8%-241K shares

EML has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

EML Net Leverage

Q4 2023: 1.6xQ1 2024: 1.5xQ2 2024: 1.1xQ3 2024: 1.4xQ4 2024: 1.2xQ1 2025: 1.4xQ2 2025: 1.3xQ3 2025: 1.5xQ1 2026: 1.6xQ2 2026: 1.7xQ3 2026: 2.0xQ4 2026: 1.8x
Q4 2023: 1.6xQ1 2024: 1.5xQ2 2024: 1.1xQ3 2024: 1.4xQ4 2024: 1.2xQ1 2025: 1.4xQ2 2025: 1.3xQ3 2025: 1.5xQ1 2026: 1.6xQ2 2026: 1.7xQ3 2026: 2.0xQ4 2026: 1.8x
QuarterNet LeverageStatus
Q3 20261.8xHealthy
Q2 20262.0xHealthy
Q1 20261.7xHealthy
Q4 20251.6xHealthy
Q3 20251.5xHealthy
Q2 20251.3xHealthy
Q1 20251.4xHealthy
Q4 20241.2xHealthy

EML's net debt is about 1.8 years of its operating earnings (EBITDA), up from 1.5 years a year ago.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

EML Weekly Momentum

MetricValueStatus
RSI65.5Neutral
Stochastic66.3Neutral

EML's weekly RSI is 65 (neutral) and its Stochastic is 66 (neutral).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

EML PE vs Industrials Sector

MetricEMLSector medianRelative
PE17x24x29% below
PE %67589 pts above

EML is trading at 17x earnings, a 29% discount to the Industrials sector's median of 24x.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

EML Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$25.919% above
20 week MA$25.720% above
50 week MA$22.537% above
100 week MA$23.233% above
200 week MA$23.431% above

EML has the edge over RKLB on trend strength, trading above more of its moving averages.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.

EML Yearly ROI

YearStart priceEnd priceROI
2020$30.0$24.6-18%
2021$24.6$24.8+0.8%
2022$24.8$20.3-18%
2023$20.3$22.0+8.4%
2024$22.0$26.6+21%
2025$26.6$20.5-23%
2026 YTD$20.5$30.8+51%

EML has the edge over RKLB on returns for 2026, with the stronger performance.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

Give your agent the market.

Get API key